AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma (Q40297313)

19 September 2017

AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma (English)

1 reference

19 September 2017

Thomas C Harding

1

1 reference

19 September 2017

Alshad S Lalani

2

1 reference

19 September 2017

Byron N Roberts

3

1 reference

19 September 2017

Satya Yendluri

4

1 reference

19 September 2017

Bo Luan

5

1 reference

19 September 2017

Kathryn E Koprivnikar

6

1 reference

19 September 2017

Melissa Gonzalez-Edick

7

1 reference

19 September 2017

Guang Huan-Tu

8

1 reference

19 September 2017

Randy Musterer

9

1 reference

19 September 2017

Melinda J VanRoey

10

1 reference

19 September 2017

Tomoko Ozawa

11

1 reference

19 September 2017

Richard A LeCouter

12

1 reference

19 September 2017

Dennis Deen

13

1 reference

19 September 2017

Peter J Dickinson

14

1 reference

19 September 2017

Karin Jooss

15

1 reference

19 September 2017

31 March 2006

1 reference

19 September 2017

1 reference

19 September 2017

13

1 reference

19 September 2017

5

1 reference

19 September 2017

956-966

1 reference

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

A glioma-derived analog to platelet-derived growth factor: demonstration of receptor competing activity and immunological crossreactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

An angiogenic growth factor is expressed in human glioma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

The vasculature of experimental brain tumours. Part 1. A sequential light and electron microscope study of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Interstitial fluid pressure in intracranial tumours in patients and in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Development of novel targeted therapies in the treatment of malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Central nervous system failure in patients with chronic myelogenous leukemia lymphoid blast crisis and Philadelphia chromosome positive acute lymphoblastic leukemia treated with imatinib (STI-571).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Convection-enhanced delivery of macromolecules in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Subthalamic GAD gene therapy in a Parkinson's disease rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

VEGF-Trap: a VEGF blocker with potent antitumor effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

A syngeneic mouse glioma model for study of glioblastoma therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

Regulation of angiogenesis by hypoxia: role of the HIF system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

A Clone of the MOCH-1 Glial Tumor in Culture: Multiple Phenotypes Expressed Under Different Environmental Conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2006.02.004

1 reference

19 September 2017

1 reference